PHXM

PHAXIAM Therapeutics S.A. PHXM

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PHXM MEIP NYMXF MTVA TRAW CSCI PIRS DOMH ELEV ATON
6M -33.05 % 63.30 % 16.48 % 28.09 % 82.07 % 0.00 % 98.54 % 8.28 % -39.91 % -54.35 %
YTD -35.42 % 20.39 % 6.00 % -53.80 % -69.55 % -0.37 % 0.00 % 355.96 % -38.67 % 10.86 %
1Y -62.92 % 13.70 % -41.11 % -61.47 % -47.62 % -26.49 % -4.96 % 192.35 % -54.38 % -4.75 %
3Y -95.51 % -59.61 % -71.35 % -61.47 % -85.33 % -54.67 % -95.03 % -18.52 % -70.80 % -95.88 %
5Y -95.88 % -95.06 % -94.73 % -61.47 % -97.18 % -54.67 % -94.89 % -40.19 % -96.81 % -96.99 %
10Y -98.73 % -90.92 % -97.06 % -61.47 % -100.00 % -54.67 % -93.82 % -98.67 % -96.81 % -98.07 %
From the beginning -98.73 % -99.97 % -98.37 % -61.47 % -100.00 % -54.67 % -93.82 % -100.00 % -96.81 % -97.54 %

Dividend

MEI Pharma, Inc.

Dominari Holdings Inc.